Related Experiment Video
Updated: Jun 28, 2026

Intermittent Binge-Intake Model in Mice
Published on: January 10, 2025
Successful duloxetine treatment of a binge eating disorder: a case report
1Università degli Studi di Firenze, Firenze, Italy.
Abstract:
We report the successful treatment of a case of refractory binge eating disorder (BED) with duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, resulting in complete remission of the patient's bingeing behaviours. This case is discussed in the context of the existing literature on the psychopharmacology of BED. Results demonstrate that inhibition of 5-HT and noradrenaline reuptake by duloxetine markedly reduces food intake, suggesting that this may be a novel approach for the treatment of obesity.
Related Concept Videos
Binge Eating Disorders
Bulimia Nervosa
Taste Buds and Receptors
Antidepressant Drugs: MAOIs and Other Agents
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
